These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24322509)

  • 1. Recombinant human erythropoietin for treating treatment-resistant depression: a double-blind, randomized, placebo-controlled phase 2 trial.
    Miskowiak KW; Vinberg M; Christensen EM; Bukh JD; Harmer CJ; Ehrenreich H; Kessing LV
    Neuropsychopharmacology; 2014 May; 39(6):1399-408. PubMed ID: 24322509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder.
    Miskowiak KW; Vinberg M; Harmer CJ; Ehrenreich H; Knudsen GM; Macoveanu J; Hansen AR; Paulson OB; Siebner HR; Kessing LV
    Trials; 2010 Oct; 11():97. PubMed ID: 20942940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of recombinant erythropoietin on inflammatory markers in patients with affective disorders: A randomised controlled study.
    Vinberg M; Weikop P; Olsen NV; Kessing LV; Miskowiak K
    Brain Behav Immun; 2016 Oct; 57():53-57. PubMed ID: 27181179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of recombinant erythropoietin on plasma brain derived neurotrophic factor levels in patients with affective disorders: a randomised controlled study.
    Vinberg M; Miskowiak K; Hoejman P; Pedersen M; Kessing LV
    PLoS One; 2015; 10(5):e0127629. PubMed ID: 26011424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Erythropoietin on Hippocampal Volume and Memory in Mood Disorders.
    Miskowiak KW; Vinberg M; Macoveanu J; Ehrenreich H; Køster N; Inkster B; Paulson OB; Kessing LV; Skimminge A; Siebner HR
    Biol Psychiatry; 2015 Aug; 78(4):270-7. PubMed ID: 25641635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of erythropoietin on memory-relevant neurocircuitry activity and recall in mood disorders.
    Miskowiak KW; Macoveanu J; Vinberg M; Assentoft E; Randers L; Harmer CJ; Ehrenreich H; Paulson OB; Knudsen GM; Siebner HR; Kessing LV
    Acta Psychiatr Scand; 2016 Sep; 134(3):249-59. PubMed ID: 27259062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial.
    Miskowiak KW; Ehrenreich H; Christensen EM; Kessing LV; Vinberg M
    J Clin Psychiatry; 2014 Dec; 75(12):1347-55. PubMed ID: 25099079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neural correlates of improved executive function following erythropoietin treatment in mood disorders.
    Miskowiak KW; Vinberg M; Glerup L; Paulson OB; Knudsen GM; Ehrenreich H; Harmer CJ; Kessing LV; Siebner HR; Macoveanu J
    Psychol Med; 2016 Jun; 46(8):1679-91. PubMed ID: 26996196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of recombinant human erythropoietin on cognition and neural activity in remitted patients with mood disorders and first-degree relatives of patients with psychiatric disorders: a study protocol for a randomized controlled trial.
    Petersen JZ; Schmidt LS; Vinberg M; Jørgensen MB; Hageman I; Ehrenreich H; Knudsen GM; Kessing LV; Miskowiak KW
    Trials; 2018 Nov; 19(1):611. PubMed ID: 30400939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
    J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of erythropoietin on cognitive side-effects of electroconvulsive therapy in depression: A randomized, double-blind, placebo-controlled trial.
    Miskowiak KW; Petersen JZ; Macoveanu J; Ysbæk-Nielsen AT; Lindegaard IA; Cramer K; Mogensen MB; Hammershøj LG; Stougaard ME; Jørgensen JL; Schmidt LS; Vinberg M; Ehrenreich H; Hageman I; Videbech P; Gbyl K; Kellner CH; Kessing LV; Jørgensen MB
    Eur Neuropsychopharmacol; 2024 Feb; 79():38-48. PubMed ID: 38128460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of pretreatment interhemispheric hippocampal asymmetry on improvement in verbal learning following erythropoietin treatment in mood disorders: a randomized controlled trial.
    Miskowiak KW; Forman JL; Vinberg M; Siebner HR; Kessing LV; Macoveanu J
    J Psychiatry Neurosci; 2020 May; 45(3):198-205. PubMed ID: 31804779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin as an add-on treatment for cognitive side effects of electroconvulsive therapy: a study protocol for a randomized controlled trial.
    Schmidt LS; Petersen JZ; Vinberg M; Hageman I; Olsen NV; Kessing LV; Jørgensen MB; Miskowiak KW
    Trials; 2018 Apr; 19(1):234. PubMed ID: 29673379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Treatments to Improve Cognitive Function in Mood Disorder: Suggestions From Trials Using Erythropoietin.
    Miskowiak KW; Rush AJ; Gerds TA; Vinberg M; Kessing LV
    J Clin Psychiatry; 2016 Dec; 77(12):e1639-e1646. PubMed ID: 27835716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of erythropoietin on emotional processing biases in patients with major depression: an exploratory fMRI study.
    Miskowiak KW; Favaron E; Hafizi S; Inkster B; Goodwin GM; Cowen PJ; Harmer CJ
    Psychopharmacology (Berl); 2009 Nov; 207(1):133-42. PubMed ID: 19705104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of erythropoietin on body composition and fat-glucose metabolism in patients with affective disorders.
    Vinberg M; Højman P; Pedersen BK; Kessing LV; Miskowiak KW
    Acta Neuropsychiatr; 2018 Dec; 30(6):342-349. PubMed ID: 29880069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of erythropoietin on cognitive impairment and prefrontal cortex activity across affective disorders: A randomized, double-blinded, placebo-controlled trial.
    Macoveanu J; Petersen JZ; Mariegaard J; Jespersen AE; Cramer K; Bruun CF; Madsen HØ; Jørgensen MB; Vinberg M; Fisher PM; Knudsen GM; Hageman I; Ehrenreich H; Kessing LV; Miskowiak KW
    J Psychopharmacol; 2024 Apr; 38(4):362-374. PubMed ID: 38519416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Comparison Design Trial of Adjunctive Riluzole for Treatment-Resistant Major Depressive Disorder.
    Mathew SJ; Gueorguieva R; Brandt C; Fava M; Sanacora G
    Neuropsychopharmacology; 2017 Dec; 42(13):2567-2574. PubMed ID: 28553836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression.
    Barbee JG; Thompson TR; Jamhour NJ; Stewart JW; Conrad EJ; Reimherr FW; Thompson PM; Shelton RC
    J Clin Psychiatry; 2011 Oct; 72(10):1405-12. PubMed ID: 21367355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.